ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 028,90
0,28%
Dow Jones
44 603,24
0,30%
DAX
22 037,83
0,48%
Brent Oil
76,82
1,18%
Bitcoin
95 228,86
-2,31%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Iterum Therapeutics PLC (ITRM)

  7. Iterum Therapeutics PLC (ITRM) Actualités

ITRM

Iterum Therapeutics (ITRM)

Iterum Therapeutics PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ITRM
DateHeureSourceTitreSymboleSociété
07/02/202522h33Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ITRMIterum Therapeutics PLC
07/02/202513h30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ITRMIterum Therapeutics PLC
07/02/202513h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ITRMIterum Therapeutics PLC
07/02/202513h00GlobeNewswire Inc.Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:ITRMIterum Therapeutics PLC
31/01/202514h00GlobeNewswire Inc.Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025NASDAQ:ITRMIterum Therapeutics PLC
10/12/202413h04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ITRMIterum Therapeutics PLC
21/11/202414h30GlobeNewswire Inc.Iterum Therapeutics Regains Full Nasdaq ComplianceNASDAQ:ITRMIterum Therapeutics PLC
14/11/202413h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ITRMIterum Therapeutics PLC
14/11/202413h00GlobeNewswire Inc.Iterum Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:ITRMIterum Therapeutics PLC
11/11/202414h00GlobeNewswire Inc.Iterum Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024NASDAQ:ITRMIterum Therapeutics PLC
28/10/202410h00PR Newswire (US)Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract InfectionsNASDAQ:ITRMIterum Therapeutics PLC
25/10/202417h03GlobeNewswire Inc.Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract InfectionsNASDAQ:ITRMIterum Therapeutics PLC
10/10/202414h30GlobeNewswire Inc.Iterum Therapeutics to Present Data at IDWeek 2024NASDAQ:ITRMIterum Therapeutics PLC
09/10/202423h00GlobeNewswire Inc.Iterum Therapeutics to Participate at the 2024 Maxim Healthcare Virtual SummitNASDAQ:ITRMIterum Therapeutics PLC
30/09/202422h15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ITRMIterum Therapeutics PLC
10/09/202413h00GlobeNewswire Inc.Iterum Therapeutics Provides Update on FDA Advisory Committee Discussion of Oral Sulopenem for the Treatment of uUTI in Adult WomenNASDAQ:ITRMIterum Therapeutics PLC
06/09/202422h30GlobeNewswire Inc.Iterum Therapeutics to Present at the 26th Annual H.C. Wainwright Global Investment ConferenceNASDAQ:ITRMIterum Therapeutics PLC
14/08/202422h15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ITRMIterum Therapeutics PLC
14/08/202413h00GlobeNewswire Inc.Iterum Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:ITRMIterum Therapeutics PLC
14/08/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ITRMIterum Therapeutics PLC
09/08/202423h28Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ITRMIterum Therapeutics PLC
07/08/202422h30GlobeNewswire Inc.Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024NASDAQ:ITRMIterum Therapeutics PLC
06/08/202423h30GlobeNewswire Inc.Iterum Therapeutics Announces Expiration and Results of Rights OfferingNASDAQ:ITRMIterum Therapeutics PLC
02/08/202422h30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ITRMIterum Therapeutics PLC
02/08/202414h00GlobeNewswire Inc.Iterum Therapeutics Broadens Patent Estate for Oral SulopenemNASDAQ:ITRMIterum Therapeutics PLC
22/07/202413h30GlobeNewswire Inc.Iterum Therapeutics Commences Rights OfferingNASDAQ:ITRMIterum Therapeutics PLC
19/07/202423h05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ITRMIterum Therapeutics PLC
17/07/202422h21Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ITRMIterum Therapeutics PLC
21/06/202414h00GlobeNewswire Inc.Iterum Therapeutics Announces FDA Advisory Committee Meeting to discuss NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract InfectionsNASDAQ:ITRMIterum Therapeutics PLC
07/06/202422h11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ITRMIterum Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:ITRM

Dernières Valeurs Consultées

EU
PX1
CAC 40
COIN
SOLUSD
Solana
EU
VIV
Vivendi
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
NKE
Nike
EU
SGO
Cie de SaintGobain
COIN
BTCUSD
Bitcoin
EU
CAP
Capgemini
EU
BN
Danone
EU
BNP
BNP Paribas
EU
AF
Air FranceKLM
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
EU
HO
Thales
COIN
DOGEUSD
Dogecoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces